Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,430,104
+$463,976 QoQ
Shares Held
13,631
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,558
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 2%
None 11%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Bank holds $41,161,477 across 11 Drug Manufacturers - General names. ABBV ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,809 | $17,221,451 | |
| 2 | LLY |
ELI LILLY & Co
|
10,367 | $12,434,490 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,245 | $3,629,482 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
13,631 | $3,430,104 | |
| 5 | AMGN |
Amgen Inc
|
2,520 | $912,541 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,528 | $779,482 | |
| 7 | NVS |
Novartis AG
|
4,797 | $751,785 | |
| 8 | PFE |
Pfizer Inc
|
24,466 | $589,140 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,430,104 | 13,631 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,966,128 | 13,638 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,127,113 | 13,686 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,182,979 | 13,747 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,594,409 | 13,977 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,833,547 | 13,524 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,414,587 | 13,588 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,683,555 | 13,589 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,178,989 | 12,704 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,307,934 | 12,674 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,964,089 | 12,674 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,892,315 | 12,695 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,777,762 | 13,195 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $2,029,735 | 12,736 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,029,659 | 12,559 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,632,396 | 12,163 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,738,978 | 11,354 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,928,297 | 11,895 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,289,413 | 9,523 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,034,796 | 9,593 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $1,039,103 | 9,225 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $957,746 | 8,850 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $863,735 | 8,061 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $770,616 | 8,798 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $732,717 | 7,463 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $527,614 | 6,925 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||